These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
584 related articles for article (PubMed ID: 9372207)
21. Regulation of corticotropin-releasing factor type 1 (CRF1) receptor messenger ribonucleic acid in the paraventricular nucleus of rat hypothalamus by exogenous CRF. Mansi JA; Rivest S; Drolet G Endocrinology; 1996 Nov; 137(11):4619-29. PubMed ID: 8895325 [TBL] [Abstract][Full Text] [Related]
22. CRF modulates glutamate transmission in the central amygdala of naïve and ethanol-dependent rats. Varodayan FP; Correia D; Kirson D; Khom S; Oleata CS; Luu G; Schweitzer P; Roberto M Neuropharmacology; 2017 Oct; 125():418-428. PubMed ID: 28807676 [TBL] [Abstract][Full Text] [Related]
23. Selective impairment of corticotropin-releasing factor1 (CRF1) receptor-mediated function using CRF coupled to saporin. Maciejewski-Lenoir D; Heinrichs SC; Liu XJ; Ling N; Tucker A; Xie Q; Lappi DA; Grigoriadis DE Endocrinology; 2000 Feb; 141(2):498-504. PubMed ID: 10650928 [TBL] [Abstract][Full Text] [Related]
24. The effects of CRF and the urocortins on the hippocampal acetylcholine release in rats. Pintér D; Balangó B; Simon B; Palotai M; Csabafi K; Dobó É; Ibos KE; Bagosi Z Neuropeptides; 2021 Aug; 88():102147. PubMed ID: 33932861 [TBL] [Abstract][Full Text] [Related]
25. Endogenous expression and in vitro study of CRF-related peptides and CRF receptors in the rat gastric antrum. Porcher C; Peinnequin A; Pellissier S; Meregnani J; Sinniger V; Canini F; Bonaz B Peptides; 2006 Jun; 27(6):1464-75. PubMed ID: 16337313 [TBL] [Abstract][Full Text] [Related]
26. Involvement of the corticotropin-releasing factor (CRF) type 2 receptor in CRF-induced thyrotropin release by the amphibian pituitary gland. Okada R; Miller MF; Yamamoto K; De Groef B; Denver RJ; Kikuyama S Gen Comp Endocrinol; 2007 Feb; 150(3):437-44. PubMed ID: 17188689 [TBL] [Abstract][Full Text] [Related]
27. Central CRF, urocortins and stress increase colonic transit via CRF1 receptors while activation of CRF2 receptors delays gastric transit in mice. Martínez V; Wang L; Rivier J; Grigoriadis D; Taché Y J Physiol; 2004 Apr; 556(Pt 1):221-34. PubMed ID: 14755002 [TBL] [Abstract][Full Text] [Related]
28. A novel water-soluble selective CRF1 receptor antagonist, NBI 35965, blunts stress-induced visceral hyperalgesia and colonic motor function in rats. Million M; Grigoriadis DE; Sullivan S; Crowe PD; McRoberts JA; Zhou H; Saunders PR; Maillot C; Mayer EA; Taché Y Brain Res; 2003 Sep; 985(1):32-42. PubMed ID: 12957366 [TBL] [Abstract][Full Text] [Related]
29. Corticotropin-releasing factor receptors and urocortins, links between the brain and the heart. Yang LZ; Tovote P; Rayner M; Kockskämper J; Pieske B; Spiess J Eur J Pharmacol; 2010 Apr; 632(1-3):1-6. PubMed ID: 20132811 [TBL] [Abstract][Full Text] [Related]
30. Brain penetrance, receptor occupancy and antistress in vivo efficacy of a small molecule corticotropin releasing factor type I receptor selective antagonist. Heinrichs SC; De Souza EB; Schulteis G; Lapsansky JL; Grigoriadis DE Neuropsychopharmacology; 2002 Aug; 27(2):194-202. PubMed ID: 12093593 [TBL] [Abstract][Full Text] [Related]
31. Lack of interaction between etifoxine and CRF1 and CRF2 receptors in rodents. Verleye M; André N; Gillardin JM Neurosci Res; 2006 Sep; 56(1):53-60. PubMed ID: 16769145 [TBL] [Abstract][Full Text] [Related]
32. Subtype-selective corticotropin-releasing factor receptor agonists exert contrasting, but not opposite, effects on anxiety-related behavior in rats. Zhao Y; Valdez GR; Fekete EM; Rivier JE; Vale WW; Rice KC; Weiss F; Zorrilla EP J Pharmacol Exp Ther; 2007 Dec; 323(3):846-54. PubMed ID: 17855476 [TBL] [Abstract][Full Text] [Related]
33. The effect of lateral septum corticotropin-releasing factor receptor 2 activation on anxiety is modulated by stress. Henry B; Vale W; Markou A J Neurosci; 2006 Sep; 26(36):9142-52. PubMed ID: 16957071 [TBL] [Abstract][Full Text] [Related]
34. Central CRF inhibits gastric emptying of a nutrient solid meal in rats: the role of CRF2 receptors. Martinez V; Barquist E; Rivier J; Taché Y Am J Physiol; 1998 May; 274(5):G965-70. PubMed ID: 9612279 [TBL] [Abstract][Full Text] [Related]
35. Corticotropin-releasing factor, urocortin 1, and their receptors in the mouse spinal cord. Korosi A; Kozicz T; Richter J; Veening JG; Olivier B; Roubos EW J Comp Neurol; 2007 Jun; 502(6):973-89. PubMed ID: 17444496 [TBL] [Abstract][Full Text] [Related]
36. Anxiogenic and antinociceptive effects induced by corticotropin-releasing factor (CRF) injections into the periaqueductal gray are modulated by CRF1 receptor in mice. Miguel TT; Nunes-de-Souza RL Horm Behav; 2011 Aug; 60(3):292-300. PubMed ID: 21723867 [TBL] [Abstract][Full Text] [Related]
37. Presynaptic CRF1 receptors mediate the ethanol enhancement of GABAergic transmission in the mouse central amygdala. Nie Z; Zorrilla EP; Madamba SG; Rice KC; Roberto M; Siggins GR ScientificWorldJournal; 2009 Jan; 9():68-85. PubMed ID: 19151899 [TBL] [Abstract][Full Text] [Related]
38. Distribution of corticotropin-releasing factor (CRF) receptor binding in the mouse brain using a new, high-affinity radioligand, [ Tan LA; Vaughan JM; Perrin MH; Rivier JE; Sawchenko PE J Comp Neurol; 2017 Dec; 525(18):3840-3864. PubMed ID: 28842924 [TBL] [Abstract][Full Text] [Related]
39. Anxiogenic and aversive effects of corticotropin-releasing factor (CRF) in the bed nucleus of the stria terminalis in the rat: role of CRF receptor subtypes. Sahuque LL; Kullberg EF; Mcgeehan AJ; Kinder JR; Hicks MP; Blanton MG; Janak PH; Olive MF Psychopharmacology (Berl); 2006 May; 186(1):122-32. PubMed ID: 16568282 [TBL] [Abstract][Full Text] [Related]
40. Agonist bias and agonist-dependent antagonism at corticotrophin releasing factor receptors. Tasma Z; Wills P; Hay DL; Walker CS Pharmacol Res Perspect; 2020 Jun; 8(3):e00595. PubMed ID: 32529807 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]